Deals of the day-Mergers and acquisitions

Incyte

08/06/2026 14:34

Adds: Johnson & Johnson, Blackstone Inc; Updates: Incyte, Sanpaolo
June 8 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Monday:
     
** Johnson & Johnson <JNJ.N> said it will acquire biotech Firefly Bio for $1 billion in cash, as it looks to expand its cancer drug pipeline.
nL4N42G150
     
** Incyte <INCY.O> said it has agreed to acquire Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics, in a deal worth up to $2 billion, expanding its pipeline for blood disorder therapies.
nL4N42G10A
     
** Blackstone Inc <BX.N> is seeking to sell more than $2 billion of stakes it holds in private investment funds, the Financial Times reported, in a deal that would test investor appetite for older private equity assets.
nL4N42G0S2
     
** Italy's top banking group Intesa Sanpaolo <ISP.MI> made a €30.6 billion ($35 billion) unsolicited cash-and-share bid to buy smaller rival Monte dei Paschi di Siena <BMPS.MI> in what could create the euro zone's second-largest lender.
nL4N42G0DE
     
     
** U.S. group Ingredion <INGR.N> has struck a deal to buy Britain's Tate & Lyle <TATE.L> for £2.7 billion ($3.6 billion) in cash to create a leading speciality food and beverage ingredients company.
nL6N42G0CY
     
** Intesa Sanpaolo <ISP.MI> has taken a 3% stake in Generali <GASI.MI> to prevent the insurer from building a defensive stake in Italy's biggest bank, CEO Carlo Messina told analysts.
nS8N3EV02A
     

 (Compiled by Rajarshi Roy and Megavarshini G. Somasundaram in Bengaluru)
 ((Rajarshi.Roy@thomsonreuters.co))